Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk ...

An international clinical trial has identified a medication that can help prevent ... This is the first clinical trial of an oral antiviral drug to show significant protection against COVID-19. If ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...

Long COVID is arguably the most significant hangover from the pandemic. Here's what has been learned, and what remains ...

Five years after the WHO declared the COVID global outbreak to be a pandemic, frontline health care workers reflect on what they remember of the early days of COVID.